1501 — Shanghai INT Medical Instruments Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapNeutral

Market Cap
HK$4.69bn
Enterprise Value
HK$4.37bn
Revenue
CNY851.95m

Annual income statement for Shanghai INT Medical Instruments Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	358	465	586	753	852
Cost of Revenue
Gross Profit	234	276	332	438	538
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	221	308	441	575	636
Operating Profit	137	156	145	178	216
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	137	156	144	175	213
Provision for Income Taxes
Net Income After Taxes	117	140	134	153	190
Minority Interest
Net Income Before Extraordinary Items
Net Income	121	143	132	156	192
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	121	143	132	156	181
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.731	0.857	0.782	0.916	1.1
Dividends per Share